An infection with RSV is a coldlike nuisance for most healthy people, but it can be life-threatening for the very young and the elderly
. There are no vaccines for babies yet so the new drug, a lab-made antibody that helps the immune system fight off the virus, is expected to fill a critical need.
The drug, developed by AstraZeneca and Sanofi, is expected to be ready in the fall before the RSV season, typically November through March. In the U.S., about 58,000 children younger than 5 are hospitalized for RSV each year and several hundred die. A panel of outside advisers to the Centers for Disease Control and Prevention recommended the one-time shot for infants born just before or during the RSV season and for those less than 8 months old before the season starts. They also recommended a dose for some 8- to 19-months-olds at higher risk of a serious illness from RSV.“We had a terribly bad RSV season last year and I’m thrilled that we have a new tool to protect our infants,” Dr. Mandy Cohen told The Associated Press earlier this week.
The drug, to be sold under the brand name Beyfortus, is expected to cost $495 per dose, and to be covered by insurance. Panelists acknowledged that it will be a challenge at first to give the shot and for providers to be reimbursed by insurers.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
CDC to meet on FDA-approved RSV vaccine, local mother details twins' health scare last fallRSV is the leading cause of hospitalization in infants under a year old in the United States every year.
Baca lebih lajut »
Babies should get new drug that prevents RSV, CDC panel saysInfants should get a new drug to protect them against a respiratory virus that sends tens of thousands of American children to the hospital each year, heath advisers recommended Thursday.
Baca lebih lajut »
Babies should get new drug that prevents RSV, CDC panel saysInfants should get a new drug to protect them against a respiratory virus that sends tens of thousands of American children to the hospital each year, health advisers recommended Thursday.
Baca lebih lajut »
CDC advisers vote to recommend new preventive RSV shot for all infants | CNNAll infants under 8 months of age should get a new antibody shot to protect against hospitalization with respiratory syncytial virus, or RSV, according to a panel of independent experts that advises the United States Centers for Disease Control and Prevention on its immunization recommendations.
Baca lebih lajut »
Babies born in fall and winter should get RSV shots, CDC panel recommendsMany babies should get a shot soon after birth to protect them from RSV, or respiratory syncytial virus, a panel of the Centers for Disease Control and Prevention's outside advisers voted Thursday.
Baca lebih lajut »